Detalhe da pesquisa
1.
Zilebesiran, an RNA Interference Therapeutic Agent for Hypertension.
N Engl J Med
; 389(3): 228-238, 2023 Jul 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37467498
2.
Effect of Sacubitril/Valsartan on Cognitive Function in Patients With Heart Failure With Preserved Ejection Fraction: A Prespecified Analysis of PARAGON-HF.
Circulation
; 2024 Jun 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38841854
3.
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction.
N Engl J Med
; 387(12): 1089-1098, 2022 09 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36027570
4.
Outpatient Worsening Among Patients With Mildly Reduced and Preserved Ejection Fraction Heart Failure in the DELIVER Trial.
Circulation
; 148(22): 1735-1745, 2023 11 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37632455
5.
Clinical Characteristics and Outcomes in Patients With Heart Failure: Are There Thresholds and Inflection Points in Left Ventricular Ejection Fraction and Thresholds Justifying a Clinical Classification?
Circulation
; 148(9): 732-749, 2023 08 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37366061
6.
Dapagliflozin and Apparent Treatment-Resistant Hypertension in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The DELIVER Trial.
Circulation
; 148(24): 1945-1957, 2023 12 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37830208
7.
Patient Characteristics, Outcomes, and Effects of Dapagliflozin According to the Duration of Heart Failure: A Prespecified Analysis of the DELIVER Trial.
Circulation
; 147(14): 1067-1078, 2023 04 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36876483
8.
Sex Differences in Characteristics, Outcomes, and Treatment Response With Dapagliflozin Across the Range of Ejection Fraction in Patients With Heart Failure: Insights From DAPA-HF and DELIVER.
Circulation
; 147(8): 624-634, 2023 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36342789
9.
Association of Sacubitril/Valsartan versus Valsartan with Blood Pressure Changes, and Symptomatic Hypotension: The PARAGLIDE-HF Trial.
J Card Fail
; 2024 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38802053
10.
Heart Failure, Investigator-Reported Sleep Apnea and Dapagliflozin: A Patient-Level Pooled Meta-Analysis of DAPA-HF and DELIVER.
J Card Fail
; 30(3): 436-448, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38104937
11.
Anthropometric measures and adverse outcomes in heart failure with reduced ejection fraction: revisiting the obesity paradox.
Eur Heart J
; 44(13): 1136-1153, 2023 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36944496
12.
Investigator-reported ventricular arrhythmias and mortality in heart failure with mildly reduced or preserved ejection fraction.
Eur Heart J
; 44(8): 668-677, 2023 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36632831
13.
Dapagliflozin and diuretic utilization in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial.
Eur Heart J
; 44(31): 2930-2943, 2023 08 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37220093
14.
Importance of cystatin C in estimating glomerular filtration rate: the PARADIGM-HF trial.
Eur Heart J
; 44(24): 2202-2212, 2023 06 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37051752
15.
Stroke in patients with heart failure and reduced or preserved ejection fraction.
Eur Heart J
; 44(31): 2998-3013, 2023 08 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37358785
16.
Sacubitril/valsartan in heart failure with mildly reduced or preserved ejection fraction: a pre-specified participant-level pooled analysis of PARAGLIDE-HF and PARAGON-HF.
Eur Heart J
; 44(31): 2982-2993, 2023 08 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37210743
17.
Heart failure, peripheral artery disease, and dapagliflozin: a patient-level meta-analysis of DAPA-HF and DELIVER.
Eur Heart J
; 44(24): 2170-2183, 2023 06 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37220172
18.
RNA Interference With Zilebesiran for Mild to Moderate Hypertension: The KARDIA-1 Randomized Clinical Trial.
JAMA
; 331(9): 740-749, 2024 03 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38363577
19.
SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials.
Lancet
; 400(10354): 757-767, 2022 09 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36041474
20.
Operational challenges and mitigation measures during the COVID-19 pandemic-Lessons from DELIVER.
Am Heart J
; 263: 133-140, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37220822